New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Johnson & Johnson
JNJ
Shape
US Flag

NYSE

386B

Drug Manufacturers - General

Next Earning date - 15 Oct 2024

386B

Drug Manufacturers - General

Next Earning date - 15 Oct 2024

160.29USD
Shape-0.21 ( -0.13%)
favorite-chart

Relative Strenght

14
favorite-chart

Volume Buzz

-47%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 6, 2024
1W -1.09 % 1M -3.79 % 3M 11.02 % 1Y 4.30 %

Key Metrics

Shape
  • Market Cap

    385.86B


  • Shares Outstanding

    2.41B


  • Share in Float

    2.40B


  • Dividende

    4.96


  • Earning Date

    15 Oct 2024


  • Price Target

    160.29


  • Average Volume

    6.60M


  • Beta

    0.518


  • Range

    143.13-168.85


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.jnj.com


  • Sector

    Healthcare


Fundamentals

Shape

15.29x

P/E Ratio

4.46x

P/S Ratio

5.39x

P/B Ratio

0.6

Debt/Equity

43.9%

Net Margin

$6.6

EPS

How JNJ compares to sector?

P/E Ratio

Relative Strength

Shape

JNJ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$91B

Shape306%

2025-Revenue

$8.51

Shape336%

2025-EPS

$30B

Shape228%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Johnson Rice

downgrade

Previous: Overweight

2024-07-23

Now: Neutral

Johnson Rice

upgrade

Previous: Overweight

2024-04-18

Now: Buy

Johnson Rice

upgrade

Previous: Overweight

2024-04-18

Now: Negative

Wells Fargo

downgrade

Previous: Overweight

2023-12-28

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-2%

2.55
vs 2.6

Q1.23

arrow
arrow

+10%

2.35
vs 2.13

Q2.23

arrow
arrow

+0%

2.68
vs 2.67

Q3.23

arrow
arrow

+8%

2.8
vs 2.59

Q4.23

arrow
arrow

+4%

2.66
vs 2.55

Q4.23

arrow
arrow

-10%

2.29
vs 2.55

Q1.24

arrow
arrow

+15%

2.71
vs 2.35

Q2.24

arrow
arrow

+5%

2.82
vs 2.68

Q3.24

arrow
arrow

-22%

2.19
vs 2.8

Q4.24

arrow
arrow

-1%

2.27
vs 2.29

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-14%

20B  vs 23.3B

Q1.23

arrow
arrow

-4%

23.7B  vs 24.8B

Q2.23

arrow
arrow

-11%

20.9B  vs 23.4B

Q3.23

arrow
arrow

-10%

21.5B  vs 24B

Q4.23

arrow
arrow

+7%

21.4B  vs 20B

Q4.23

arrow
arrow

+7%

21.4B  vs 20B

Q1.24

arrow
arrow

-10%

21.4B  vs 23.7B

Q2.24

arrow
arrow

+7%

22.4B  vs 20.9B

Q3.24

arrow
arrow

+3%

22.1B  vs 21.5B

Q4.24

arrow
arrow

+5%

22.5B  vs 21.4B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+6%

0.06
vs 0.06

Q1.23

arrow
arrow

+5%

0.05
vs 0.06

Q2.23

arrow
arrow

0%

-0.00
vs 0.05

Q3.23

arrow
arrow

+7%

0.07
vs -0.00

Q4.23

arrow
arrow

+37%

0.37
vs 0.07

Q4.23

arrow
arrow

+6%

0.06
vs 0.37

Q1.24

arrow
arrow

+5%

0.05
vs 0.06

Q2.24

arrow
arrow

+7%

0.07
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

3689

3.7K
vs 3.7K

-1%

Q4.22

arrow
arrow

3855

3.9K
vs 3.7K

5%

Q1.23

arrow
arrow

3790

3.8K
vs 3.9K

-2%

Q2.23

arrow
arrow

3811

3.8K
vs 3.8K

1%

Q3.23

arrow
arrow

3725

3.7K
vs 3.8K

-2%

Q4.23

arrow
arrow

3908

3.9K
vs 3.7K

5%

Q1.24

arrow
arrow

3876

3.9K
vs 3.9K

-1%

Q2.24

arrow
arrow

3756

3.8K
vs 3.9K

-3%

Earnings Growth

Latest News